Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma.

Abstract

CA125 and CA72-4 are members of a family of high-molecular weight glycosylated proteins and are commonly considered as biomarkers in the diagnosis of ovarian and gastric cancer, respectively. However, recent studies have revealed that these two markers may be of clinical value in the diagnosis of pancreatic cancer. As the availability of data regarding CA72… (More)

Topics

Cite this paper

@article{Wang2014ClinicalVO, title={Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma.}, author={Zi Wang and Yaping Tian}, journal={Molecular and clinical oncology}, year={2014}, volume={2 2}, pages={265-268} }